Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aromasin Adjuvant Therapy in Chinese Early Breast Cancer
NCT01176916Phase 4Completed
- Sponsor
- Pfizer
- Start
- Feb 2011
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of exemestane in breast cancer, sponsored by Pfizer. Started Feb 2011; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01176916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01176916.